PURPOSE: To evaluate a patient-specific single photon emission computed tomography (SPECT)-based method of dose calculation for treatment planning of yttrium-90 ((90)Y) microsphere selective internal radiotherapy (SIRT). METHODS AND MATERIALS: Fourteen consecutive (90)Y SIRTs for colorectal liver metastasis were retrospectively analyzed. Absorbed dose to tumor and normal liver tissue was calculated by partition methods with two different tumor/normal liver vascularity ratios: an average 3:1 and a patient-specific ratio derived from pretreatment technetium-99m macroaggregated albumin SPECT. Tumor response was quantitatively evaluated from fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography scans. RESULTS: Positron emission tomography showed a significant decrease in total tumor standardized uptake value (average, 52%). There was a significant difference in the tumor absorbed dose between the average and specific methods (p = 0.009). Response vs. dose curves fit by linear and linear-quadratic modeling showed similar results. Linear fit r values increased for all tumor response parameters with the specific method (+0.20 for mean standardized uptake value). CONCLUSION: Tumor dose calculated with the patient-specific method was more predictive of response in liver-directed (90)Y SIRT.
PURPOSE: To evaluate a patient-specific single photon emission computed tomography (SPECT)-based method of dose calculation for treatment planning of yttrium-90 ((90)Y) microsphere selective internal radiotherapy (SIRT). METHODS AND MATERIALS: Fourteen consecutive (90)Y SIRTs for colorectal liver metastasis were retrospectively analyzed. Absorbed dose to tumor and normal liver tissue was calculated by partition methods with two different tumor/normal liver vascularity ratios: an average 3:1 and a patient-specific ratio derived from pretreatment technetium-99m macroaggregated albumin SPECT. Tumor response was quantitatively evaluated from fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography scans. RESULTS: Positron emission tomography showed a significant decrease in total tumor standardized uptake value (average, 52%). There was a significant difference in the tumor absorbed dose between the average and specific methods (p = 0.009). Response vs. dose curves fit by linear and linear-quadratic modeling showed similar results. Linear fit r values increased for all tumor response parameters with the specific method (+0.20 for mean standardized uptake value). CONCLUSION:Tumor dose calculated with the patient-specific method was more predictive of response in liver-directed (90)Y SIRT.
Authors: Renaud Lhommel; Larry van Elmbt; Pierre Goffette; Marc Van den Eynde; François Jamar; Stanislas Pauwels; Stephan Walrand Journal: Eur J Nucl Med Mol Imaging Date: 2010-04-27 Impact factor: 9.236
Authors: Stephan Walrand; Glenn D Flux; Mark W Konijnenberg; Roelf Valkema; Eric P Krenning; Renaud Lhommel; Stanislas Pauwels; Francois Jamar Journal: Eur J Nucl Med Mol Imaging Date: 2011-03-11 Impact factor: 9.236
Authors: Yuni K Dewaraja; Se Young Chun; Ravi N Srinivasa; Ravi K Kaza; Kyle C Cuneo; Bill S Majdalany; Paula M Novelli; Michael Ljungberg; Jeffrey A Fessler Journal: Med Phys Date: 2017-10-28 Impact factor: 4.071
Authors: Yuni K Dewaraja; Theresa Devasia; Ravi K Kaza; Justin K Mikell; Dawn Owen; Peter L Roberson; Matthew J Schipper Journal: J Nucl Med Date: 2019-05-30 Impact factor: 10.057
Authors: Alejandro Bertolet; Eric Wehrenberg-Klee; Mislav Bobić; Clemens Grassberger; Joseph Perl; Harald Paganetti; Jan Schuemann Journal: Phys Med Biol Date: 2021-12-29 Impact factor: 3.609
Authors: Lidia Strigari; Mark Konijnenberg; Carlo Chiesa; Manuel Bardies; Yong Du; Katarina Sjögreen Gleisner; Michael Lassmann; Glenn Flux Journal: Eur J Nucl Med Mol Imaging Date: 2014-06-11 Impact factor: 9.236